Riverdale, NY, United States of America

Shalom Z Hirschman

This inventor holds 22 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Therapeutic Composition. Top assignees: Advanced Viral Research Corporation, Preprogen LLC, Ohr Pharmaceuticals, Inc. Active years: 1976-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shalom Z Hirschman. Retrieved from https://idiyas.com/inventor/shalom-z-hirschman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 

% Patents Active = 72.7

 

 

Average Co-Inventor Count = 1.3

ph-index = 6

Forward Citations = 220(Granted Patents)


Location History:

  • Forest Hills, NY (US) (1976 - 1980)
  • Riverdale, NY (US) (1998 - 2011)
  • Bronx, NY (US) (2018 - 2020)

Company Filing History:


Years Active: 1976-2020

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Fetal Cells
Cancer Treatment
Therapeutic Composition
Autoimmune Diseases
HIV Infections
Papillomavirus
Red Blood Cell Production
Feminine Hygienic Pads
Topical Treatment
Canine Distemper
Product R
Adenovirus Infection
22 patents (USPTO):Explore Patents

Title: Shalom Z Hirschman: Innovator in Fetal Cell Technology

Introduction

Shalom Z Hirschman is a distinguished inventor based in Riverdale, NY, recognized for his significant contributions to the field of fetal cell technology. With a remarkable total of 22 patents to his name, Hirschman has dedicated his efforts to developing non-invasive methods for obtaining fetal cells, a breakthrough that has the potential to transform prenatal diagnostics.

Latest Patents

Among his notable inventions, Hirschman’s latest patents revolve around innovative methods for collecting fetal cells from pregnant females without invasive procedures. These methods involve placing an absorbent medium in either an interlabial or intravaginal space or near the perineum at the vaginal opening. By collecting vaginal fluid containing cells in this medium, he enables the non-invasive acquisition of various types of fetal cells, including somatic cells, embryonic stem cells, fetal stem cells, and trophoblast cells. This approach not only enhances safety for mothers and their unborn children but also expands the possibilities for prenatal testing and research.

Career Highlights

Hirschman has had a significant impact on the medical and research community through his work in various companies, notably the Advanced Viral Research Corporation. His expertise and innovations have helped further research in fetal health and prenatal diagnostics, solidifying his position as a thought leader in the industry.

Collaborations

Throughout his career, Shalom Z Hirschman has collaborated with esteemed colleagues, including Bernard Friedland and Irach B Taraporewala. These partnerships have fostered a rich exchange of ideas and have contributed to the successful development of his cutting-edge technologies.

Conclusion

Shalom Z Hirschman's innovative spirit and dedication to advancing fetal cell technology underscore his vital role in the scientific community. His work not only leads to improved prenatal care but also sets the stage for future research and developments in the realm of maternal and fetal health. As he continues to push the boundaries of what is possible, his contributions are certain to leave a lasting impact on the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…